Dr. Fukuda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
155 Borthwick Ave
Ste C
Portsmouth, NH 03801Phone+1 603-828-0100Fax+1 603-828-0111
Education & Training
- MedStar Health/Georgetown-Washington Hospital CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2007 - 2010
- Keio Gujuku University School of MedicineClass of 2005
Certifications & Licensure
- ME State Medical License 2020 - 2026
- NH State Medical License 2013 - 2025
- DC State Medical License 2010 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 17 citationsEarly drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials.Dai Chihara, Ruitao Lin, Christopher R Flowers, Shanda R Finnigan, Lisa M Cordes
Lancet. 2022-08-13 - 3 citationsTrends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Canc...Dai Chihara, Erich P Huang, Shanda R Finnigan, Lisa M Cordes, Nebojsa Skorupan
Journal of Clinical Oncology. 2022-06-10 - 77 citationsImpact of MET inhibitors on survival among patients with non-small cell lung cancer harboring MET exon 14 mutations: a retrospective analysis.Mark M. Awad, Giulia Costanza Leonardi, Sasha Kravets, Suzanne E. Dahlberg, Alexander Drilon
Lung Cancer. 2019-05-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: